Skip to content
TMO$704.51-1.65(-0.23%)AI in Genomics Market Size, Share, Growth, and Competitive Analysis - Global Forecast 2026-2035 | 32.40% CAGR to USD 14.55 Billion as Precision Medicine and Drug Discovery Scale9:27:39 AM ETAMZN$271.33+5.30(+1.99%)Global Delivery Drones Market by Payload, Range, MTOW, Platform, Application, and Region - Forecast to 2031 | Healthcare and Hybrid Drones Fuel 21.6% CAGR to $7.65 Billion9:23:39 AM ETAMD$452.20-36.58(-7.48%)Heterogeneous Computing Market Size and Share - Industry Trends and Growth Forecasts (2026-2031) | Generative AI and Cloud Adoption Fuel 21.87% CAGR9:20:42 AM ETCOHR$184.02-11.20(-5.74%)Coherent Now Sees Growth Above 60% and Its First $4 Billion Quarter by Fiscal 20289:19:53 AM ETAMD$452.20-36.58(-7.48%)Global Accelerated Computing Market Size, Share, Industry Trends, and Growth Forecasts, 2026-2031 | AI Training and Edge Inference Fuel 20.19% CAGR and Custom Silicon Opportunities9:19:40 AM ETFISI$40.44+1.09(+2.77%)Virtual Desktop Infrastructure (VDI) Endpoint Market Size, Share, Trends, and Forecast 2026-2031 | Hybrid Work and Zero Trust Drive 14.48% CAGR Toward USD 9.89 Billion9:18:45 AM ETMSFT$554.86-0.94(-0.17%)Carbon-Aware Computing Platform Market Size, Share, Trends, and Growth Forecasts, 2026-2031 | AI Demand and ESG Mandates Propel Market to USD 2.95 Billion9:17:39 AM ETSOLV$89.56+0.21(+0.24%)UAE Hospital Supplies Market Size and Share Analysis, Industry Trends, and Growth Forecasts, 2026-2031 | AI Procurement and Infection-Control Demand Fuel 8.10% CAGR9:11:38 AM ETACN$267.54+3.27(+1.24%)Application Outsourcing - Market Size, Share, Industry Trends, and Growth Forecasts, 2026-2031 | Cloud, AI, and Security Demand Drive Market to USD 215.46 Billion9:10:49 AM ETCSCO$100.08-3.58(-3.45%)Desktop Virtualization Market Size, Share, Trends, and Growth Forecasts, 2026-2031 | Cloud DaaS and Hybrid Work Propel Market to USD 20.54 Billion as Asia-Pacific Leads Growth9:09:39 AM ETIBM$255.55+1.23(+0.48%)Industrial Edge Computing Market Size, Share, Trends, and Growth Forecasts, 2026-2031 | Edge AI, IIoT, and Private-5G Drive 13.24% CAGR to USD 114.87 Billion9:08:39 AM ETQUBT$6.22-0.21(-3.27%)Next-generation Computing Market Size, Share, Trends, and Growth Forecasts 2026-2031 | AI, Quantum, and Edge Investment Drive 19.02% CAGR to USD 650.48 Billion9:07:40 AM ETDIS$119.96+1.01(+0.85%)I've Been Writing About Disney Stock for 30 Years. Here's Why My Conviction Has Never Been Higher.9:07:00 AM ETKO$96.83+0.95(+0.99%)Digital Transformation (DX) - Market Size, Share, Trends, and Growth Forecasts, 2026-2031 | AI and Cloud Adoption Drive Growth to USD 5.33 Trillion9:05:41 AM ETMSFT$554.86-0.94(-0.17%)Not One Analyst Rates Microsoft a Sell. Is the Consensus View Right?9:05:39 AM ETLLY$1,433.94+15.80(+1.11%)Prediction: The Weight-Loss Drug Boom Could Be Just the Beginning for Lilly9:03:54 AM ETBNTX$90.62-0.02(-0.02%)Messenger Ribonucleic Acid (mRNA) Manufacturing Service Market Report 2026 | Capitalize on 16.2% CAGR in IVT and LNP with Thermo Fisher, Merck, Lonza and GenScript ProBio9:03:39 AM ETMSFT$554.86-0.94(-0.17%)Green IT Software Market Size, Share, Trends, and Growth Forecasts, 2026-2031 | ESG Mandates and AI Optimization Propel Market to USD 49.35 Billion9:02:40 AM ETAMZN$271.33+5.30(+1.99%)CEO Andy Jassy Just Told Investors That AWS Can Grow Revenue 40% in 2027 and 2028 and Eventually Become a Trillion-Dollar Business. Is It Enough to Get Wall Street on Board?9:02:00 AM ETTEM$72.38-3.24(-4.28%)Personal Genome Services Market Report 2026: Global Forecast to 2030 | Market to Reach $13.69 Billion by 2030 as Personalized Medicine Adoption Accelerates9:01:40 AM ETVZ$46.68+0.51(+1.10%)Verizon announces cap increases and expiration and results of its tender offers for five series of notes9:00:57 AM ETJPM$358.83+6.61(+1.88%)Chase Travel Unveils 27 Trips to Take in 2027 and Previews Expanded Luxury Vacation Homes Offering9:00:16 AM ETAMGN$480.48+2.00(+0.42%)REPATHA® LOWERS RISK OF HEART ATTACKS BY 20% COMPARED WITH EZETIMIBE IN A LARGE REAL-WORLD STUDY9:00:00 AM ETTM$217.19+17.73(+8.89%)Forterra and May Mobility Advance to Phase III of DIU’s ROADS Challenge, Bringing Autonomous Rides to Soldiers on Military Bases9:00:00 AM ET

FLGT · NASDAQ

Fulgent Genetics, Inc.

$19.68 0.00 (0.00%)

Company overview

Fulgent Genetics, Inc., together with its subsidiaries, provides COVID-19, molecular diagnostic, and genetic testing services to physicians and patients in the United States and internationally. The company offers genetic tests including Focus and Comprehensive oncology panel tests, Beacon carrier screening panels for inherited conditions, solid tumor molecular profiling for somatic cancer testing, rapid whole genome testing for children in NICU and PICU settings, newborn genetic analysis panels, single front-line tests to detect ataxia-related variants and repeat expansions through sequencing, patient-initiated picture genetics testing, whole exome and clinical exome panel tests, and whole genome, mutation, and repeat expansion testing services, as well as research service tests.

Sector
Healthcare
Industry
Medical - Diagnostics & Research
Exchange
NASDAQ
Market cap
$542M
Employees
1,313
Headquarters
El Monte, CA
CEO
Ming Hsieh
Listed
September 29, 2016
P/E
-8.27
Dividend yield
0.00%

Company financials

Revenue
$320M
Gross profit
$124M
Operating income
-$106M
EBITDA
-$58.5M
Net income
-$73.8M
EPS
-$2.38
Total assets
$1.2B
Total debt
$10.2M
Gross margin
38.71%
Net margin
-23.04%
Earnings yield
-12.09%

Revenue segmentation

By product (FY 2025)
By region (FY 2025)

Showing FY 2025

Price chart

13.8016.1318.4720.8023.13
FLGT 1D NASDAQ O19.74H19.99L19.30C19.68+0.31 (+1.60%)Vol229.86K

News

15-min delaySigned-out view is delayed 15 minutes. Log in on Pro for the live news desk.

Source
Date
Type
View
Ticker Type Headline Source Published
FLGTFulgent Genetics, Inc. Press release Personal Genome Services Market Report 2026: Global Forecast to 2030 | Market to Reach $13.69 Billion by 2030 as Personalized Medicine Adoption Accelerates GlobeNewswire
FLGTFulgent Genetics, Inc. Stock news Head to Head Survey: Agilon Health (NYSE:AGL) and Fulgent Genetics (NASDAQ:FLGT) Defense World
FLGTFulgent Genetics, Inc. Press release Fulgent to Announce Third Quarter 2026 Financial Results on Thursday, November 5, 2026 Business Wire
FLGTFulgent Genetics, Inc. Stock news PRPO vs. FLGT: Which Cancer Diagnostics Stock Has More Upside Now? Zacks Investment Research
FLGTFulgent Genetics, Inc. Press release Fulgent Reports Second Quarter 2026 Financial Results Business Wire
FLGTFulgent Genetics, Inc. Stock news Fulgent Genetics: Strong Moves By Management Keep Me Bullish Seeking Alpha
FLGTFulgent Genetics, Inc. Press release Fulgent to Announce Second Quarter 2026 Financial Results on Thursday, July 30, 2026 Business Wire
FLGTFulgent Genetics, Inc. Press release Fulgent Presents Updated FID-007 Data at ASCO 2026 Business Wire
FLGTFulgent Genetics, Inc. Legal Lowey Dannenberg, P.C. is Investigating Fulgent Genetics Inc. (NASDAQ: FLGT) for Potential Violations of the Federal Securities Laws and Encourages Investors to Contact the Firm GlobeNewswire
FLGTFulgent Genetics, Inc. Press release Fulgent Announces Rapid Oral Full Abstract Publication for FID-007 Within the Head and Neck Cancer Track Session at the ASCO 2026 Annual Meeting Business Wire
FLGTFulgent Genetics, Inc. Legal Fulgent Genetics, Inc. Shareholders Are Encouraged to Reach Out to Johnson Fistel for More Information About Potentially Recovering Their Losses GlobeNewswire
FLGTFulgent Genetics, Inc. Legal Lowey Dannenberg, P.C. is Investigating Fulgent Genetics Inc. (NASDAQ: FLGT) for Potential Violations of the Federal Securities Laws and Encourages Investors to Contact the Firm GlobeNewswire
FLGTFulgent Genetics, Inc. Press release Foundation Medicine to Launch FoundationOne®PGx, a Pharmacogenetic Offering, Through Expanded Partnership with Fulgent Genetics Business Wire
FLGTFulgent Genetics, Inc. Stock news Fulgent Genetics, Inc. (FLGT) Q1 2026 Earnings Call Transcript Seeking Alpha
FLGTFulgent Genetics, Inc. Stock news Fulgent Genetics, Inc. (FLGT) Reports Q1 Loss, Beats Revenue Estimates Zacks Investment Research
FLGTFulgent Genetics, Inc. Press release Fulgent Reports First Quarter 2026 Financial Results Business Wire
FLGTFulgent Genetics, Inc. Stock news Fulgent Genetics, Inc. (NASDAQ:FLGT) Given Average Rating of “Hold” by Analysts Defense World
FLGTFulgent Genetics, Inc. Press release Fulgent Selected to Present Rapid Oral Abstract Within the Head and Neck Cancer Track Session at the 2026 ASCO Annual Meeting Business Wire
FLGTFulgent Genetics, Inc. Legal Lowey Dannenberg, P.C. is Investigating Fulgent Genetics Inc. (NASDAQ: FLGT) for Potential Violations of the Federal Securities Laws and Encourages Investors to Contact the Firm GlobeNewswire
FLGTFulgent Genetics, Inc. Press release Fulgent to Announce First Quarter 2026 Financial Results on Friday, May 1, 2026 Business Wire
FAQ

Questions about Fulgent Genetics, Inc.

What does Fulgent Genetics, Inc. do?
Fulgent Genetics, Inc., together with its subsidiaries, provides COVID-19, molecular diagnostic, and genetic testing services to physicians and patients in the United States and internationally. The company offers genetic tests including Focus and Comprehensive oncology panel tests, Beacon carrier screening panels for inherited conditions, solid tumor molecular profiling for somatic cancer testing, rapid whole genome testing for children in NICU and PICU settings, newborn genetic analysis panels, single front-line tests to detect ataxia-related variants and repeat expansions through sequencing, patient-initiated picture genetics testing, whole exome and clinical exome panel tests, and whole genome, mutation, and repeat expansion testing services, as well as research service tests.
What is FLGT's market cap?
Fulgent Genetics, Inc. (FLGT) is a listed stock with a live quote. The latest market cap on this page is $542M.
Where is Fulgent Genetics, Inc. headquartered?
Fulgent Genetics, Inc. is headquartered in El Monte, CA.
How do I get FLGT news from the API?
Call GET /v1/news?tickers=FLGT. Add type=news, type=press_release, or type=legal to take one feed. Pro keys search articles since 2020 in real time. Free keys are delayed 15 minutes and return the last year. Signed-out visitors and Free accounts see that same year on this page. Pro sees articles since 2020.
How far back does FLGT news go?
Signed-out visitors and Free accounts see the last year of stock news, press releases, and legal notices for FLGT, 15 minutes behind, and each headline links to the publisher. Pro, including the 7-day trial, sees articles since 2020 as headlines are ingested. A Free API key returns the last year. Pro keys search articles since 2020.
Is the FLGT price on this page from the API?
The price and daily change update during the US session for every visitor. That quote is context on this page. It is not part of the news API. The chart is one candle per session from the start of 2020. 1W, 1M, and 1Y group those sessions.
Can I use the Pro plan commercially?
No. The Pro plan cannot be used for commercial work. A product you sell, work you do for a client, or redistribution of the feed needs a custom plan and a license. Email [email protected].

Real-time stock news for $15 a month.

Start a 7-day Pro trial. A card is required. REST, WebSocket, and MCP are included, with 250 REST requests a day, 1 WebSocket connection, 5 requests per second, and 2,500 WebSocket messages a day. You won't be charged during the trial. Unless you cancel, the card is billed for Pro when it ends.